Latest News about LLY
Recent news which mentions LLY
Why Hims & Hers Health Stock Just Popped
March 11, 2025
From Motley Fool
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
March 11, 2025
From Benzinga
From Motley Fool
The Reality of Trump's Tariffs
March 10, 2025
From Motley Fool
The State of Weight Loss Drugs
March 10, 2025
From Motley Fool
From Benzinga
3 Cold Stocks That Can Bounce Back This Week
March 10, 2025
From Motley Fool
3 Magnificent Growth Stocks to Buy in March
March 08, 2025
From Motley Fool
Eli Lilly's Single Monthly Maintenance Shot Of Eczema Drug Shows Completely Clear Skin At 3 Years In 50% Of Trial Patients
March 07, 2025
From Benzinga
From Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
From Benzinga
From Benzinga
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
March 06, 2025
From Benzinga
3 Monster Stocks to Hold for the Next 10 Years
March 06, 2025
From Motley Fool
From Motley Fool
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
March 06, 2025
From Benzinga
From Benzinga
From Benzinga
Nvidia, Apple, and Eli Lilly: Manufacturing the Future
March 04, 2025
From Motley Fool
From Benzinga
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath
March 04, 2025
From Benzinga
From Benzinga
These Vanguard ETFs Show Where the Smart Money Is Moving Now
March 03, 2025
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 27, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.